title: [Use of virus-inactivated plasma in apheresis treatment of thrombotic thrombocytopenic purpura: preliminary data].
abstract: Plasma exchange (TPEx) with fresh frozen plasma (FFP) or cryosupernatant plasma infusion is the treatment of choice for thrombotic thrombocytopenic purpura (TTP). The authors evaluate the preliminary data of the multicenter SIdEM study that compares virus-inactivated plasma with fresh frozen plasma (FFP) or cryosupernatant plasma in the apheretic treatment of TTP.
authors.affiliation: SC di Medicina Trasfusionale, Az. Ospedaliera di Reggio Emilia, Reggio Emilia, Italy. russi.gianpaolo@asmn.re.it
authors.forename: Gianpaolo
authors.initials: G
authors.lastname: Russi
authors.forename: Giustina
authors.initials: G
authors.lastname: De Silvestro
authors.forename: Chiara
authors.initials: C
authors.lastname: Savignano
mesh_terms: D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007558:Italy; D008297:Male; D010949:Plasma; D010951:Plasma Exchange; D010956:Plasmapheresis / Q000379:methods; D011697:Purpura, Thrombotic Thrombocytopenic / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D038301:Virus Inactivation